Itolizumab, a novel anti-CD6 monoclonal antibody: a safe and efficacious biologic agent for management of psoriasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Itolizumab, a novel anti-CD6 monoclonal antibody: a safe and efficacious biologic agent for management of psoriasis

Published:2017-01-25 Issue:3 Volume:17 Page:395-402
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Dogra Sunil¹,Uprety Shraddha²,Suresh Swaroop Hassan³

Affiliation:

1. Department of Dermatology, Venereology & Leprology Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India

2. Dept of Dermatology, Venereology and Leprology, Chitwan Medical College, Tribhuvan University, Bharatpur, Nepal

3. Department of Medical affairs, Branded Formulations India, Biocon, Bengaluru, India

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2017.1279601

Reference33 articles.

1. Secukinumab for treating plaque psoriasis

2. Psoriasis prevalence among adults in the United States

3. Prevalence and Treatment of Psoriasis in the United Kingdom

4. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The circulating proteome and brain health: Mendelian randomisation and cross-sectional analyses;Translational Psychiatry;2024-05-18

2. The circulating proteome and brain health: Mendelian randomisation and cross-sectional analyses;2023-10-03

3. CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma;Leukemia;2023-08-12

4. The circulating proteome and brain health: Mendelian randomisation and cross-sectional analyses;2023-07-31

5. Anti CD-6 Monoclonal Antibodies in the Management of Generalised Pustular Psoriasis;Indian Journal of Dermatology;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3